Ralliant (NYSE:RAL) Releases FY 2026 Earnings Guidance

Ralliant (NYSE:RAL) updated its FY 2026 earnings guidance on Tuesday. The company provided earnings per share (EPS) guidance of 2.530-2.690 for the period, compared to the consensus estimate of 2.350. The company issued revenue guidance of $2.2 billion-$2.2 billion, compared to the consensus revenue estimate of $2.2 billion. Ralliant also updated its Q2 2026 guidance to 0.580-0.640 EPS.

Analyst Upgrades and Downgrades

Several research firms have commented on RAL. Citigroup cut their price target on Ralliant from $61.00 to $51.00 and set a “buy” rating on the stock in a research report on Friday, February 6th. Morgan Stanley reaffirmed an “overweight” rating and set a $45.00 price target on shares of Ralliant in a research report on Friday, February 6th. Oppenheimer cut their price target on Ralliant from $60.00 to $50.00 and set an “outperform” rating on the stock in a research report on Friday, February 6th. Zacks Research raised Ralliant from a “strong sell” rating to a “hold” rating in a research report on Monday, April 13th. Finally, Truist Financial cut their price target on Ralliant from $62.00 to $49.00 and set a “buy” rating on the stock in a research report on Friday, February 6th. Seven research analysts have rated the stock with a Buy rating, four have assigned a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat.com, Ralliant has a consensus rating of “Moderate Buy” and a consensus price target of $50.50.

Ralliant Trading Up 4.5%

Shares of RAL stock opened at $49.36 on Tuesday. The business’s 50 day moving average is $44.32 and its two-hundred day moving average is $47.07. Ralliant has a twelve month low of $37.27 and a twelve month high of $57.02. The company has a market capitalization of $5.52 billion and a P/E ratio of 25.18. The company has a current ratio of 0.84, a quick ratio of 0.58 and a debt-to-equity ratio of 0.38.

Ralliant (NYSE:RAL) last announced its earnings results on Tuesday, May 12th. The company reported $0.57 earnings per share for the quarter. The company had revenue of $534.60 million during the quarter. Ralliant has set its FY 2026 guidance at 2.530-2.690 EPS and its Q2 2026 guidance at 0.580-0.640 EPS. Equities analysts forecast that Ralliant will post 2.37 EPS for the current year.

Ralliant Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, June 23rd. Investors of record on Monday, June 8th will be paid a $0.05 dividend. The ex-dividend date is Monday, June 8th. This represents a $0.20 dividend on an annualized basis and a dividend yield of 0.4%. Ralliant’s payout ratio is 10.20%.

Insider Buying and Selling at Ralliant

In related news, SVP Karen M. Bick sold 2,530 shares of Ralliant stock in a transaction that occurred on Thursday, March 5th. The stock was sold at an average price of $46.50, for a total value of $117,645.00. Following the sale, the senior vice president directly owned 42,652 shares in the company, valued at $1,983,318. The trade was a 5.60% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link.

Institutional Trading of Ralliant

A number of institutional investors have recently modified their holdings of the business. Virtu Financial LLC purchased a new stake in shares of Ralliant in the fourth quarter valued at approximately $221,000. T. Rowe Price Investment Management Inc. boosted its stake in shares of Ralliant by 19.7% in the fourth quarter. T. Rowe Price Investment Management Inc. now owns 3,423,268 shares of the company’s stock valued at $174,279,000 after buying an additional 563,822 shares in the last quarter. Invesco Ltd. boosted its stake in shares of Ralliant by 4.9% in the fourth quarter. Invesco Ltd. now owns 4,059,588 shares of the company’s stock valued at $206,674,000 after buying an additional 187,898 shares in the last quarter. Corient Private Wealth LLC boosted its stake in shares of Ralliant by 53.3% in the fourth quarter. Corient Private Wealth LLC now owns 23,401 shares of the company’s stock valued at $1,192,000 after buying an additional 8,132 shares in the last quarter. Finally, Mercer Global Advisors Inc. ADV boosted its stake in shares of Ralliant by 58.8% in the fourth quarter. Mercer Global Advisors Inc. ADV now owns 10,150 shares of the company’s stock valued at $517,000 after buying an additional 3,760 shares in the last quarter.

Ralliant Company Profile

Ralliant, Inc (NYSE: RAL) is a medical technology company focused on enabling point-of-care cell therapy solutions in the field of regenerative medicine. The company develops and markets systems that isolate, concentrate and store adipose-derived stromal vascular fraction (SVF) cells directly from a patient’s own fat tissue, facilitating same-day, autologous treatments without the need for extensive laboratory infrastructure.

The company’s core product portfolio includes proprietary device platforms and single-use processing kits engineered to streamline the workflow for clinicians.